PMID: 9426083Jan 13, 1998Paper

Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency

The European Respiratory Journal
M PalmqvistJ Lötvall

Abstract

Salmeterol and formoterol are two long-acting beta2-agonists for inhalation, currently being used in clinical practice. The aim of the present study was to investigate the onset of action, duration of effect and potency of these two beta2-agonists in asthmatic patients. Patients (n=28) were included on the basis of salbutamol stepwise reversibility (100, 100 and 200 microg, given cumulatively; total reversibility > or =15%). In a double-blind placebo-controlled crossover study, the bronchodilating properties of formoterol 6, 12 and 24 microg were compared with the effects of salmeterol 50 microg. Formoterol was given via Turbuhaler and salmeterol via Diskhaler, and forced expiratory volume in one second (FEV1) was monitored during 12 h. Formoterol at all doses had a more rapid onset than salmeterol as judged from bronchodilation at 3 min after the dose. Formoterol at all doses had a similar duration of effect to salmeterol 50 microg, as judged from bronchodilation at 12 h after dose administration. When the relative potency of the two drugs was compared, salmeterol 50 microg was estimated to correspond to formoterol 9 microg (95% confidence interval: 3-19 microg). We confirm that formoterol and salmeterol are both long-acting b...Continue Reading

Citations

Aug 10, 2010·Naunyn-Schmiedeberg's Archives of Pharmacology·Elizabeth M RosethorneSteven J Charlton
May 5, 2004·Pulmonary Pharmacology & Therapeutics·Hanneke J van der WoudeRené Aalbers
Jun 18, 2002·European Journal of Pharmacology·Bertil Waldeck
Jan 20, 1999·Respiratory Medicine·N RingdalR Pauwels
Aug 12, 2009·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Edward M KerwinMitchell Goldman
Sep 26, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Harold KaiserLiza O'Dowd
Oct 5, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Brian J LipworthBrian J O'Connor
Aug 9, 2006·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·William E Berger
May 17, 2003·Pulmonary Pharmacology & Therapeutics·Jaro AnkerstEva Weibull
Feb 16, 2008·Nature Reviews. Immunology·Stephen T Holgate, Riccardo Polosa
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·K ConantE O Major
Feb 6, 2010·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Wallace P AdamsLawrence Yu
Aug 30, 2002·Thorax·D PriceUNKNOWN FLOW (Eformoterol in the management of mild astmha--eformoterol Turboinhaler with budesonide Turbohaler) research group
Jan 25, 2006·Respiration; International Review of Thoracic Diseases·Ruta DubakieneSatu Lähelmä
Jul 3, 1999·American Journal of Respiratory and Critical Care Medicine·M PalmqvistJ Lötvall
Oct 6, 2001·American Journal of Respiratory and Critical Care Medicine·J C Kips, R A Pauwels
May 23, 2002·American Journal of Respiratory and Critical Care Medicine·Nicola A HananiaBurton F Dickey
Sep 6, 2013·Respiratory Research·Kentaro MizutaCharles W Emala
Jul 23, 2004·International Journal of Adolescent Medicine and Health·Petr Pohunek, Asher Tal
Jul 16, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Ekaterina S GladyshevaRobert L Owens
Mar 18, 2010·Therapeutics and Clinical Risk Management·Peter N HuynhKenny Yc Kwong
Jul 5, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·R J Hancox, D R Taylor
Nov 3, 2009·Annals of Thoracic Medicine·Mohamed S Al-MoamaryMaha Al Dabbagh
Jul 24, 2014·European Journal of Internal Medicine·A PapiN Scichilone
Oct 9, 2008·Der Internist·M SierenC Taube
Jul 19, 2005·Expert Opinion on Investigational Drugs·Mario CazzolaJan Lötvall
Nov 7, 2003·Journal of Pharmaceutical Sciences·David C ApperleyTorsten Malmstrom
Mar 12, 2005·Journal of Pharmaceutical Sciences·Teerapol SrichanaNiwan Tanmanee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.